What's new

Type-II variations: questions and answers

Type-II variations: questions and answers

Feb 18, 2025 - 15:38
 0
Type-II variations: questions and answers
Type-II variations: questions and answers
Read More

Tags:

Previous Article

Changing the labelling and package leaflet (Article 61(3) notifications)

Next Article

Worksharing: questions and answers

Related Posts

Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Dafiro HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0